Where I see patients (1)
My reviews
Selected research
-
Emerging GPRC5D-Targeted therapies for multiple myeloma: a comprehensive review.
Expert opinion on investigational drugs
-
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells.
Blood
-
BCMA-directed CAR T-cell therapy in patients with multiple myeloma and CNS involvement.
Blood advances
Clinical trials
A Study to Evaluate Preventive Treatments for Talquetamab-related Oral Toxicity
Dysgeusia is defined as total WETT score of 25th percentile or below according to the Normative WETT-SA53 percentile table. Taste assessment will be performed using taste strips (WETT). Four concentrations (4=lowest concentration,...
Recruiting
4.9